IJSDR
IJSDR
INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15

Issue: May 2024

Volume 9 | Issue 5

Impact factor: 8.15

Click Here For more Info

Imp Links for Author
Imp Links for Reviewer
Research Area
Subscribe IJSDR
Visitor Counter

Copyright Infringement Claims
Indexing Partner
Published Paper Details
Paper Title: Efficacy of Carboxymethylcellulose 1% vs Rebamipide 2% in Dry eye disease [DED]: a comparative study
Authors Name: Dr.Bhagyashree Satish Dhage , Dr.Valay Parekh , Dr.Roopa Naik , Dr.Madhurika Kalbande
Unique Id: IJSDR2304072
Published In: Volume 8 Issue 4, April-2023
Abstract: Dry eye disease [DED] is an ocular film disease impacting millions of people globally. It is characterised by an unstable tear film leading to symptoms such as eye irritation, redness, foreign body sensation, photophobia and blurring of vision. This comparative study aims to evaluate the efficacy of Carboxymethylcellulose (CMC) 1% versus Rebamipide 2% eye drops in the management of dry eye disease (DED). It was a single-blinded prospective comparative study A total of 100 DED patients were enrolled in the study, and after randomisation, they received either CMC 1% or Rebamipide 2% eye drops. The patients were instructed to instil one drop in each eye four times a day for 12 weeks. Follow-up visits were scheduled at four and twelve weeks, during which tear film function and tear secretion tests were performed. The results indicated that both CMC 1% and Rebamipide 2% were effective in improving symptoms of DED. The rebamipide group gave better results at the end of 12 weeks in the improvement of multiple evaluating criteria as compared to the CMC group. Both drugs decreased the severity of dry eye disease. Also, the efficacy of rebamipide has been found to be better than carboxymethyl cellulose. This study suggests that both CMC 1% and Rebamipide 2% may be useful in the management of DED.
Keywords: Dry eye disease Rebamipide CMC
Cite Article: "Efficacy of Carboxymethylcellulose 1% vs Rebamipide 2% in Dry eye disease [DED]: a comparative study", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.8, Issue 4, page no.382 - 388, April-2023, Available :http://www.ijsdr.org/papers/IJSDR2304072.pdf
Downloads: 000337366
Publication Details: Published Paper ID: IJSDR2304072
Registration ID:204890
Published In: Volume 8 Issue 4, April-2023
DOI (Digital Object Identifier):
Page No: 382 - 388
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631

Click Here to Download This Article

Article Preview

Click here for Article Preview







Major Indexing from www.ijsdr.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

Track Paper
Important Links
Conference Proposal
ISSN
DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to GET DOI and Hard Copy Related
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Creative Commons License
This material is Open Knowledge
This material is Open Data
This material is Open Content
Social Media
IJSDR

Indexing Partner